Andersen, Andreas http://orcid.org/0000-0001-8190-5140
Lund, Asger http://orcid.org/0000-0003-1212-3764
Knop, Filip K. http://orcid.org/0000-0002-2495-5034
Vilsbøll, Tina http://orcid.org/0000-0002-0456-6787
Article History
First Online: 4 May 2018
Competing interests
: A.A. and A.L. have no competing interests. Until 2018, T.V. served on scientific advisory panels and/or speakers’ bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk and Sanofi. Thereafter, she has no competing interests. F.K.K. has served on scientific advisory panels and/or speaker's bureaus and served as a consultant to and/or received research support from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Fractyl, Gubra, Merck Sharp & Dohme, Novo Nordisk, Sanofi and Zealand Pharma.